Expression of PTEN and survivin in cervical cancer: Promising biological markers for early diagnosis and prognostic evaluation

British Journal of Biomedical Science

Volumn 69, Issue 4, 2012, Pages 143-146

  Lu, D ^a   Qian, J ^a   Yin, X ^a   Xiao, Qin ^b   Wang, C ^b   Zeng, Y ^c  

^a CLINICAL MEDICAL COLLEGE OF YANGZHOU UNIVERSITY   (China)

^b YANGZHOU UNIVERSITY   (China)

^c BEIJING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Biomarkers; Carcinoma, squamous cell; Cervical intraepithelial neoplasia; PTEN protein, human; Survivin protein, human

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN; PTEN PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; APOPTOSIS; CANCER GENE THERAPY; CANCER GROWTH; CANCER SIZE; CLINICAL EVALUATION; ECTROPION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; UTERINE CERVIX EPITHELIUM; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; UTERINE CERVIX TUMOR;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MIDDLE AGED; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 84873155331     PISSN: 09674845     EISSN: None     Source Type: Journal    
DOI: 10.1080/09674845.2012.12069142     Document Type: Article

References (11)

1. Hlobilkova A, Knillova J, Svachova M, Skypalova P, Krystof V, Kolar Z. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells. Anticancer Res 2006; 26 (2A): 1015-22.
2. Ai Z, Yin L, Zhou X et al. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 2006; 107 (4): 746-56. (Pubitemid 44232667)
3. Yuan XJ, Whang YE. PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 2002; 21 (2): 319-27. (Pubitemid 34102140)
4. Mayo MW, Madrid LV, Westerheide SD et al. PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit. J Biol Chem 2002; 277 (13): 11116-25. (Pubitemid 34952872)
5. Qi M, Anderson AE, Chen DZ, Sun S, Auborn KJ. Indole-3-carbinol prevents PTEN loss in cervical cancer in vivo. Mol Med 2005; 11 (1-12): 59-63.
6. Yang LQ, Fang DC, Wang RQ, Yang SM. Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol 2004; 10 (1): 22-5.
7. Kim HS, Shiraki K, Park SH. Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 2002; 22 (2A): 805-8. (Pubitemid 34475232)
8. Zhao P, Meng Q, Liu LZ, You YP, Liu N, Jiang BH. Regulation of survivin by PI3K/Akt/p70S6K1 pathway. Biochem Biophys Res Commun 2010; 395 (2): 219-24.
9. Koul D, Takada Y, Shen R, Aggarwal BB, Yung WK. PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells. Biochem Biophys Res Commun 2006; 350 (2): 463-71. (Pubitemid 44500673)
10. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr Opin Urol 2007; 17 (5): 303-8. (Pubitemid 47344615)
11. Guha M, Plescia J, Leav I, Li J, Languino LR, Altieri DC. Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res 2009; 69 (12): 4954-8.